Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
Person › Details

Krystle Gibbs (Ten Bridge Communications (US))

Gibbs, Krystle (Ten Bridge Communications 201703)


Organisation Organisation Ten Bridge Communications (US)
Products Product public relations / investor relations / marcom (services)

Arsanis, Inc.. (3/1/17). "Press Release: Arsanis to Present at the Cowen and Company 37th Annual Health Care Conference". Waltham, MA & Vienna.

Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies (mAbs) for pre-emptive and post-infection treatment of serious infectious diseases, announced today that René Russo, PharmD, BCPS, chief executive officer, will present a company overview at the Cowen and Company 37th Annual Health Care Conference in Boston, MA.

The presentation will take place on Wednesday, March 8, 2017, at 10:00 a.m. EDT.

About Arsanis, Inc.

Arsanis is a clinical-stage biotechnology company leading the development of targeted monoclonal antibodies (mAbs) for pre-emptive therapy and treatment of serious infectious diseases. The company’s current programs address pathogenic processes selectively, aiming to preserve the healthy microbiome and potentially allowing Arsanis to address critical infections without contributing to the problem of resistance. The company is building a broad product pipeline addressing the most important infectious diseases that threaten patients globally. Its lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in a Phase 2 clinical study for the prevention of S. aureus pneumonia in high-risk patients.

Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH). For more information, please visit the Arsanis website at


Media Contact:
Ten Bridge Communications
Krystle Gibbs, 508-479-6358


Investor Contact:
Michael Gray, 781-819-5201
Chief Financial and Chief Business Officer

Record changed: 2018-05-19


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Krystle Gibbs

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top